Harvard Catalyst Profiles

James Cook University, Australia	MBBS
University of Oxford, United Kingdom	MSc
University of New South Wales, Australia	PhD
Fellow, Royal Australasian College of Physicians, Australia	FRACP
Fellow, American Society of Nephrology, United States	FASN

Dr Brendon Neuen is a Nephrologist and Director of the Kidney Trials Unit at Royal North Shore Hospital, and Senior Research Fellow at The George Institute for Global Health in Sydney, Australia. He graduated with 1st Class Honours and the Academic Medal from James Cook University, holds Masters in Global Health from the University of Oxford, PhD from the University of New South Wales. He is a Fellow of the Royal Australasian College of Physicians and the American Society of Nephrology.

He is widely recognised for his expertise in cardio-renal-metabolic medicine and is involved in the leadership of several large-scale trials evaluating therapeutic strategies to slow CKD progression and reduce cardiovascular risk. Dr Neuen established the SGLT2 Meta-Analysis Cardio-Renal Trialists' Consortium, bringing together data on >90,000 patients to better understand the effects of this class of medicines in different types of patients. His work has directly informed more than 25 major international and national guidelines, position papers and scientific statements which define optimal care for people with type 2 diabetes and kidney disease including the KDIGO guidelines and American Diabetes Association Standards of Care.

• Kidney Insufficiencies, Chronic
• Type 2 Diabetes Mellitus
• Clinical Trials, Randomized
• Epidemiology